ACM
ABBV icon

Americafirst Capital Management’s AbbVie ABBV Stock Holding History

Americafirst Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,826
Closed -$1.22M – 190
2017
Q2 		$1.22M Buy
+16,826
New +$1.13M 1.54% 19
2017
Q1 		– Sell
-1,752
Closed -$110K – 154
2016
Q4 		$110K Sell
1,752
-213
-11% -$13K 0.12% 155
2016
Q3 		$124K Hold
1,965
– – 0.1% 154
2016
Q2 		$122K Buy
+1,965
New +$120K 0.08% 155

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Americafirst Capital Management's ABBV Position: Q3 2017 in Review

Americafirst Capital Management sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 16,826 shares — an estimated $1.22M sold.

Americafirst Capital Management first reported a position in ABBV in Q2 2016 and held it in 4 quarters. The position peaked at $1.22M in Q2 2017. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Americafirst Capital Management reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • Americafirst Capital Management sold 16,826 AbbVie shares in Q3 2017, an estimated $1.22M.
  • Americafirst Capital Management first reported a position in AbbVie in Q2 2016 and held it in 4 quarters.
  • Americafirst Capital Management's AbbVie position peaked at $1.22M in Q2 2017.
  • 1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.